{
    "code": "60001064",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001064",
    "time": "2022-10-21 03:46:33",
    "許可證字號": "衛部菌疫輸字第001064號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/12\/12",
    "發證日期": "106\/12\/12",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000106400",
    "中文品名": "安制巴注射液劑 750IU\/mL",
    "英文品名": "Oncaspar&#174; (pegaspargase) injection 750IU\/mL",
    "適應症": "Oncaspar作為化學治療的一成分，用於治療急性淋巴細胞白血病(ALL)。",
    "劑型": "27D注射液劑",
    "包裝": "5毫升玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分",
    "監視期限": "111\/12\/12",
    "主成分略述": "Pegaspargase",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "1316101100  新加坡商施維雅股份有限公司臺灣分公司",
    "申請商地址": "台北市中山區松江路168號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS9330000  EXELEAD, INC.",
            "製造廠廠址": "6925 GUION ROAD, INDIANAPOLIS, IN 46268, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥及成品製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1000000150",
            "成分名稱": "Pegaspargase",
            "含量描述": "",
            "含量": "750.0000000000",
            "單位": "IU\/ML"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛部菌疫輸字第001064號111.09.07_核定本-111-09-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001064&Seq=004&Type=9"
        },
        {
            "title": "Outer Box_2018.12.19-107-12-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001064&Seq=003&Type=8"
        },
        {
            "title": "Label_2018.12.19-107-12-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001064&Seq=002&Type=8"
        }
    ]
}